Home - Medical Policies - Florida
Policies & Guidelines
- Advanced Imaging
- Behavioral Health
- Chronic Condition Management
- Genetic Testing
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pre-Service Review (Precertification/Predetermination)
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Mandatory Site of Service Policy
The Mandatory Site of Service policy is part of the Provider-Administered Drug Review Program. The primary objective of Mandatory Site of Service is to guide the administration of select drug infusions to the most economic and clinically appropriate place of treatment:
- Patients receiving ongoing medical specialty drug infusions in an outpatient facility are required to transition the administration of their infusions to a home setting.
- The patient must have home infusion benefits.
- The patient and the provider must agree to transition care to the alternate setting.
- The physician must approve the use of the alternative place of treatment as clinically appropriate for the patient's infusion.
- All drugs included require precertification through Magellan Rx.
- When required, the home infusion provider will obtain all necessary nursing precertifications as specified by the patient's benefits.
Review the policy below for full details.
Policy # | Policy Title | Print View |
---|---|---|
PH-90001 | Mandatory Site of Service Management Policy |
Node: bclrgrpappp1002.corp.bcbsal.org:8080